Klara, a New York-based digital health company, raised $15m in funding.
The round was co-led by Gradient Ventures and Frist Cressey Ventures with participation from existing backers FirstMark Capital, Lerer Hippeau, Project A, and Stage 2 Capital. In conjunction with the funding, Darian Shirazi, General Partner at Gradient Ventures, and Navid Farzad, Partner at Frist Cressey Ventures are joining Klara’s Board of Directors.
The company intends to use the funds to grow its team, further enhance its core product, and build out AI-driven automation including fully integrated patient intake, payments, and more. It will also continue to grow its capabilities to enable multiple healthcare organizations such as practices, pharmacies and labs to jointly communicate with patients in one place.
Co-founded by co-CEOs Simon Lorenz and Simon Bolz, Klara provides an end-to-end patient engagement platform that enables medical organizations to provide patients with an outstanding experience through intuitive communication, streamlined workflows, and virtual visits. By integrating with a customer’s EHR and PM system, Klara intelligently automates many routine workflows across the patient journey, including scheduling, pre-visit instructions, reminders, intake, no-show engagement, follow-up and more. The platform is built specifically to support both in-person and virtual patient journeys.